MeVis Medical Solutions AG

Share Issue/Capital Change • Nov 14, 2007

News Details

Ad-hoc | 14 November 2007 19:25

MeVis Medical Solutions AG: MeVis Medical Solutions AG sets offer price and offer volume

MeVis Medical Solutions AG / IPO

Release of an Ad hoc announcement according to § 15 WpHG, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---

Bremen, 14 November 2007 – MeVis Medical Solutions Aktiengesellschaft,
together with the syndicate banks M.M.Warburg & CO (Lead Manager /
Bookrunner) and Landesbank Baden-Württemberg (Co-Lead Manager) today set
the offer price for the shares of MeVis Medical Solutions AG at EUR 55.00
per share. The offer was oversubscribed.

The offer price is therefore at the bottom end of the EUR 55.00 to EUR
65.00 per share price range. The offering consisted of 776,866 shares, of
which 520,000 shares came from a capital increase from authorised capital,
resolved by the management board on November 10, 2007 and subsequently
approved by the supervisory board, 159,366 shares from the holdings of
existing shareholders as well as up to 97,500 shares from a greenshoe
option granted by the existing shareholders to M.M. Warburg & CO. All
offered shares have been allocated. The offer volume will, provided that
the greenshoe option is fully exercised, amount to EUR 42.7 million, of
which the offering proceeds for the company will be EUR 28.6 million. The
registered capital of MeVis Medical Solutions AG now amounts to EUR
1.820.000,00. The allocated shares approximate 42,7 per cent of the
registered capital.

Trading will begin in the regulated market (Prime Standard) of the
Frankfurt Stock Exchange on November 16, 2007.

Additional Information:

ISIN: DE 000A0LBFE4
WKN: A0LBFE

This Ad-hoc Release and the information it contains constitute neither in
the Federal Republic of Germany nor in any other country an offer to sell
nor an invitation to buy the securities of MeVis Medical Solutions AG, in
particular not when such an offer or invitation is forbidden or not
permitted. Potential investors are urged to inform themselves of any such
restrictions and to observe them. A decision to invest in the shares of
MeVis Medical Solutions AG must be taken only on the basis of the
securities prospectus, as published on the website www.mevis.de. This Ad
hoc release and the information is contains may not be distributed outside
the Federal Republic of Germany, and in particular not in the United States
of America, to U.S. persons in the meaning of Regulation S of the United
States Securities Act of 1933 in the current version, or to publications
with a general distribution in the United States of America. Every
violation of these restrictions may constitute a violation of the
securities regulations in certain countries and in the United States of
America in particular. The shares of MeVis Medical Solutions AG are not
offered publicly for sale outside Germany.

The information contained in this Ad-hoc Release are not intended for
distribution in the United States of America, Canada, Australia or Japan.

IR Contact

Dr. Olaf Sieker
CFO
Tel +49 421 22495 36
Email: olaf.sieker@mevis.de

14.11.2007 Financial News transmitted by DGAP

Language: English
Issuer: MeVis Medical Solutions AG
Universitätsallee 29
28359 Bremen
Deutschland
Phone: +49 421 330 74-0
Fax: +49 421 330 74-50
E-mail: office.mms@mevis.de
Internet: http://www.mevis.de
ISIN: DE000A0LBFE4
WKN: A0LBFE
Listed: Regulierter Markt in Frankfurt (Prime Standard)

Notierung vorgesehen / Designated to be listed: Regulierter Markt in Frankfurt (Prime Standard)

End of News DGAP News-Service

---